Cambridge Healthtech Institute

Preliminary Agenda Announced for Circulating Tumor Cells at Molecular Medicine Tri-Conference. Over 3000 life science and drug discovery professionals will be present in San Francisco February 15 - 20, 2015.

A conference dedicated to new antibacterial drugs development, both biologics and small molecule, as well as to the market access and pricing for new antibacterial agents.

Drug Discovery Teams to Unite for 3 Days of Learning & Collaboration - Free Passes Provide Access to Keynote Presentations by Chas Bountra, Martin Tolar, Andrew Hopkins and an Expansive Exhibit Hall

Thought-leaders to discuss in vitro tumor models of tumor microenvironment for new cancer target and drug discovery

Dr. Wells of the University of Pittsburgh will discuss "An All-Human Microphysiologic Liver System for Carcinoma Metastasis" at this conference - part of the 2nd annual FAST: Functional Analysis & Screening Technologies Congress.

Novartis, AstraZeneca and Merck to lead an assembly of drug discovery teams in discussing maximizing information in early drug discovery with phenotypic screening

CHI's event takes place on November 17-18, 2014 in Boston, MA. We are accepting scientific posters from industry & academic researchers on improving the screening success of drugs using 3D models & phenotypic screening.

R&D Teams will Gather in Boston to Discuss Complex Cellular Models Predictive of Human Response to Improve Early Decision Making

John R. Yates, Ph.D., Ernest W. Hahn Professor, Chemical Physiology and Molecular and Cellular Neurobiology at The Scripps Research Institute will deliver the plenary keynote address at the 14th Annual meeting (January 19-23, San Diego, California).

Bringing Industry, Academia and Regulatory Authorities Together to Produce Safe and Efficacious Products for the Clinic and Beyond